Medication info
Lozacin (Losartan Potassium)

Lozacin (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
Shin Poong Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
For domestic use: 30 tablets/bottle, 300 tablets/bottle For export: 30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 200502119 · Notified 2005.08.10 · Insurance code 648504480

Summary

Main use
Treatment of hypertension and type 2 diabetic nephropathy with hypertension
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be divided and administered orally twice daily, or, if necessary, increased to 100 mg once daily. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed when administered concomitantly with hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used glucose-lowering agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). No initial dose adjustment is necessary in elderly patients aged 75 years or younger. Elderly patients over 75 years of age: An initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced effective circulating blood volume (e.g., patients being treated with diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). For patients with a history of hepatic impairment, consider administering a lower dose. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents aged 6 years or older who weigh at least 20 kg but less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50 mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years or older who weigh at least 50 kg: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
Shin Poong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and type 2 diabetic nephropathy with hypertension

  • Hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication is used for the treatment of hypertension, and is also effective in treating kidney disease in patients with type 2 diabetes who have hypertension. It helps control hypertension to reduce the risk of cardiovascular disease and protect kidney function. Therefore, it is used to improve hypertension and associated complications.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be divided and administered orally twice daily, or, if necessary, increased to 100 mg once daily. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed when administered concomitantly with hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used glucose-lowering agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). No initial dose adjustment is necessary in elderly patients aged 75 years or younger. Elderly patients over 75 years of age: An initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced effective circulating blood volume (e.g., patients being treated with diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). For patients with a history of hepatic impairment, consider administering a lower dose. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents aged 6 years or older who weigh at least 20 kg but less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50 mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years or older who weigh at least 50 kg: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Precautions

This medication can cause severe harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so women who are pregnant or could become pregnant should not take it. Patients allergic to any ingredient in this medication, those with severe liver disease, or patients with certain genetic diseases should not take this medication. Elderly patients or those with impaired kidney function, and patients with hyperkalemia require special caution when administering this medication, and blood pressure or blood test results should be checked frequently. While this medication generally has good tolerance, side effects such as dizziness, muscle cramps, cough, and indigestion may occur, so if any adverse symptoms occur, consult a physician. Severe side effects such as excessively low blood pressure or irregular heartbeats may occur, so seek immediate treatment if such symptoms arise. This medication may interact with other specific drugs, so inform healthcare providers of any other medications you are taking. During treatment, avoid using potassium supplements or salt substitutes containing potassium, and it is advisable not to consume grapefruit juice. Women who are pregnant or breastfeeding should avoid taking this medication, and if it is necessary to take it, must consult a doctor and discontinue breastfeeding. This medication has not been sufficiently tested for safety and efficacy in children or pediatric patients with very poor kidney function, hence should not be used. In case of overdose, blood pressure reduction or changes in heart rate may occur, requiring immediate medical treatment, and this medication is not removed by hemodialysis, so caution is needed. Store this medication out of the reach of children, and avoid transferring it to another container.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle cramps
  • back pain
  • leg pain
  • dizziness
  • congestion
Show 123 more
  • upper respiratory infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • swelling
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm scaling
  • hemolysis
  • facial edema
  • fever
  • orthostatic effect
  • syncope
  • angina pectoris
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • anorexia
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory reduction
  • decreased libido
  • memory impairment
  • migraine
  • neurosensitivity
  • sensory abnormalities
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnia
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photosensitivity reactions
  • itching
  • rash
  • sweating
  • urticaria
  • blurred vision
  • eye burning
  • pain
  • conjunctivitis
  • taste disorder
  • tinnitus
  • vision loss
  • erectile dysfunction
  • nocturia
  • increased urgency
  • urethral infection
  • vascular edema
  • vasculitis
  • anaphylaxis-like syndrome
  • liver function abnormalities
  • hepatitis
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • elevated creatine kinase
  • rhabdomyolysis
  • dry cough
  • erythema multiforme
  • hyponatremia
  • elevated ALT
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular extrasystole
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. Additionally, it is advisable to store it in a cool, dry place at a temperature between 15 and 30 degrees Celsius.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

For domestic use: 30 tablets/bottle, 300 tablets/bottle For export: 30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.